For the first time in GLP-1 history, three fundamentally different options have converged at the same price point. The Wegovy pill starts at $149/month. Foundayo starts at $149/month. And compounded semaglutide from multiple 503A pharmacies starts at $99–$149/month. The price question has been answered. The real question is: which one is worth $149?

The Head-to-Head Comparison

FactorWegovy PillFoundayoCompounded Semaglutide
MoleculeSemaglutide (peptide)Orforglipron (non-peptide)Semaglutide (peptide)
AdministrationDaily pill, AM fastingDaily pill, any timeWeekly injection
Max weight loss~17% (adherent)~11% (highest dose)~15% (est. from trial data)
FDA approvedYesYesNo
Food restrictions30-min AM fast requiredNoneN/A (injection)
Dose flexibility4 fixed levels6 fixed levelsUnlimited custom titration
Starting price$149/mo$149/mo$99–$149/mo
Therapeutic dose price$349/mo$199–$349/mo$149–$249/mo
Insurance eligibleYes (copay ~$25)Yes (copay ~$25)Rarely
Medicare Bridge eligibleYes ($50)Yes ($50)No
NeedlesNoneNoneYes (small gauge)
Regulatory riskNoneNoneOngoing

The Starting-Dose Trap

All three options advertise entry pricing at $149. But this is the dose-escalation price — the starter dose that's designed to acclimate your body and minimize side effects. Nobody stays here. The real question is: what does the therapeutic dose cost?

At therapeutic doses, the price gap reopens. Wegovy pill's 25mg dose (the one that produced 16.6% weight loss) costs $349/month self-pay. Foundayo's highest doses settle around $199–$349/month. Compounded semaglutide at the 2.4mg equivalent ranges from $149–$249/month.

Over 12 months at therapeutic dose: Wegovy pill costs approximately $4,188. Foundayo costs approximately $2,388–$4,188. Compounded semaglutide costs approximately $1,788–$2,988. The annual gap is $1,200–$2,400 — real money for most patients.

Who Wins in Each Scenario

You have good insurance → Wegovy pill or Foundayo. With commercial insurance and a manufacturer savings card, your copay drops to $25/month or less. FDA approval means your insurance is more likely to cover it, and you get the regulatory safety net.

You're on Medicare → Medicare Bridge. If you qualify, $50/month for brand Wegovy, Zepbound, or Foundayo is unbeatable. No contest.

You're uninsured or underinsured → Compounded. Without insurance, the therapeutic-dose gap makes compounded semaglutide the clear financial winner, especially at higher doses. And the custom titration flexibility is a genuine clinical advantage.

You hate needles → Foundayo. Not Wegovy pill — because Foundayo's no-restriction dosing is significantly easier to maintain than Wegovy's AM fasting requirement. If needle-free convenience is your top priority, Foundayo is the answer.

You want maximum weight loss → Compounded semaglutide or Wegovy pill. Both deliver semaglutide — the molecule with the strongest weight loss data. Compounded offers weekly injection convenience and dose flexibility. Wegovy pill offers FDA approval and no needles (if you can maintain the fasting protocol).

Compare Every GLP-1 Option

Side-by-side pricing, efficacy, and convenience for every pathway available in July 2026.

Full Comparison Table →